Objects
Lai, F., Guo, S. T., Norman, J., Liu, T., Hersey, P., Zhang, X. D., Jin, L., Jiang, C. C., Wang, C. Y., Croft, A., Chi, M. N., Tseng, H-Y., Farrelly, M., Atmadibrata, B.. Nature Publishing Group; 2013. Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3.
Chi, M., Chen, J., Ye, Y., Tseng, Hsin-Yi, Lai, F., Tay, K. H., Jin, L., Guo, S. T., Jiang, C. C., Zhang, X. D.. Bentham Science Publishers; 2014. Adipocytes contribute to resistance of human melanoma cells to chemotherapy and targeted therapy.
Jiang, C. C., Lai, F., Zhang, X. D., Tay, K. H., Croft, A., Rizos, H., Becker, T. M., Yang, F., Liu, H., Thorne, R. F., Hersey, P.. Macmillan Publishers; 2010. Apoptosis of human melanoma cells induced by inhibition of B-RAFᵛ⁶⁰⁰ᴱ involves preferential splicing of bimS.
Hersey, P., Wroblewski, D., Lai, F., Jiang, C. C., Zhang, X. D.. Wiley-Blackwell Publishing; 2011. Targeting anti-apoptotic mechanisms for reversal of resistance to BRAF inhibitors in melanoma.
Guo, S. T., Chi, M. N., Yan, X. G., Farrelly, M., Wang, F. H., Lai, F., Wang, J. F., Li, Y. P., Ackland, S., Scott, R., Agoulnik, I. U., Hondermarck, H., Yang, R. H., Thorne, R. F., Liu, T., Zhang, X. D., Jiang, C. C., Guo, X. Y., Zan, L. K., Wang, C. Y., Xi, Y. F., Jin, L., Croft, A., Tseng, H.-Y.. Nature Publishing Group; 2016. INPP4B is an oncogenic regulator in human colon cancer.